Social anxiety disorder and antibodies against glial cells in the cerebrospinal fluid

This is the first description of a case with evidence of a possible antibody-mediated cerebellar dysfunction associated with social anxiety disorder. The testing for all characterized neuronal/glial antibodies showed only weakly positive recoverin antibodies in the serum, which, however, were not detectable in the CSF. Therefore, novel CSF antibodies directed against cell nuclei of the Bergmann glia in the cerebellum could be assumed. DMI alterations in the cerebellum were in principle compatible with neuroinflammation with edematization and cellular activation. In addition, the further DMI alterations in the striatum and the fronto-temporal generators of EEG slowing suggest an involvement of the "anxiety network". Further immunopsychiatric research in anxiety disorders might contribute to identifying an autoimmune subtype and potentially immunomodulatory treatment options.

Authors

Institutions

Publication Details

Journal
Brain Behavior & Immunity - Health
Published
2025-07-19
DOI
https://doi.org/10.1016/j.bbih.2025.101064
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Social anxiety disorder and antibodies against glial cells in the cerebrospinal fluid

Bernd Feige, Katharina Domschke, Nils Venhoff, Katharina von Zedtwitz et al.
Brain Behavior & Immunity - Health
Tryptophan and brain disorders
article

Social anxiety disorder and antibodies against glial cells in the cerebrospinal fluid

Bernd Feige, Katharina Domschke, Nils Venhoff, Katharina von Zedtwitz, Miriam A. Schiele, Ludger Tebartz van Elst, Harald Prüß, Jessica A. Weiser, Simon Maier, Raphael J. Dressle, Dominique Endres, Kathrin Nickel, Alexander Rau
article en

Abstract

This is the first description of a case with evidence of a possible antibody-mediated cerebellar dysfunction associated with social anxiety disorder. The testing for all characterized neuronal/glial antibodies showed only weakly positive recoverin antibodies in the serum, which, however, were not detectable in the CSF. Therefore, novel CSF antibodies directed against cell nuclei of the Bergmann glia in the cerebellum could be assumed. DMI alterations in the cerebellum were in principle compatible with neuroinflammation with edematization and cellular activation. In addition, the further DMI alterations in the striatum and the fronto-temporal generators of EEG slowing suggest an involvement of the "anxiety network". Further immunopsychiatric research in anxiety disorders might contribute to identifying an autoimmune subtype and potentially immunomodulatory treatment options.

Brain Behavior & Immunity - HealthVol. 48
University of Freiburg (DE), University Medical Center Freiburg (DE), German Center for Neurodegenerative Diseases (DE), German Centre for Cardiovascular Research (DE), Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 82%
Tryptophan and brain disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.